Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$50.24

0.23 (0.46%)

07:00
10/14/16
10/14
07:00
10/14/16
07:00

Bristol-Myers receives positive CHMP opinion for Opdivo

Bristol-Myers Squibb announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of Opdivo for the treatment of adult patients with relapsed or refractory classical Hodgkin lymphoma after autologous stem cell transplant and treatment with brentuximab vedotin. The CHMP recommendation will now be reviewed by the European Commission, which has the authority to approve medicines for the European Union. The CHMP positive opinion is based on data from the Phase 2 CheckMate -205 and the Phase 1 CheckMate -039 trials, evaluating patients with relapsed or refractory cHL after ASCT and treatment with brentuximab vedotin. These results showed Opdivo delivered an objective response rate, as assessed by an independent radiologic review committee, of 66%. In CheckMate -205 and -039, among all patients (safety population: n=263), the most common adverse events (reported in at least 20%) were fatigue (32.3%), diarrhea (28.9%), pyrexia (27.1%) and cough (25.9%).

  • 27

    Oct

  • 31

    Oct

  • 06

    Nov

BMY Bristol-Myers
$50.24

0.23 (0.46%)

09/28/16
ROTH
09/28/16
NO CHANGE
Target $23
ROTH
Buy
Nektar price target raised to $23 from $19 at Roth Capital
Roth Capital analyst Michael Higgins raised his price target for Nektar (NKTR) to $23 from $19 after the company and Bristol-Myers (BMY) announced a clinical collaboration to evaluate the combination of the latter's anti-PD-1 antibody, Opdivo, with NKTR-214. The analyst reiterates a Buy rating on Nektar's shares.
10/10/16
LEER
10/10/16
NO CHANGE
LEER
Outperform
Leerink sees Bristol-Myers sliding after Merck's 'spectacular' Keytruda data
Leerink analyst Seamus Fernandez said Bristol-Myers' (BMY) Checkmate-026 data presented at the European Society of Medical Oncology meeting was disappointing, noting there was no signal of benefit on progression-free survival or overall survival and only "modest differentiation" on response rate in the 88 patients with PDL1 biomarker positivity greater than or equal to 50%. Meanwhile, Merck (MRK) presented "spectacular" data for Keytruda monotherapy at the meeting, said Fernandez, who expects Bristol shares to be down "significantly" today in light of the meeting presentations. The analyst, who still thinks Bristol has a significant opportunity to compete with Merck's Keytruda in the PDL1 high portion of the market, keeps an Outperform rating on Bristol shares, which are down nearly 6% in pre-market trading.
10/13/16
GSCO
10/13/16
DOWNGRADE
GSCO
Buy
Bristol-Myers downgraded to Buy from Conviction Buy at Goldman
Goldman analyst Jami Rubin removed Bristol-Myers from the Conviction Buy List and lowered its price target to $67 from $75 saying disappointing CM-26 data adds a greater level of uncertainty to future trials. He continues to believe is well positioned for 2017, and view the shares as very attractive over the long-term.
10/13/16
10/13/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Bristol-Myers (BMY) downgraded to Buy from Conviction Buy at Goldman with analyst Jami Rubin saying disappointing CM-26 data adds a greater level of uncertainty to future trials. 2. Pfizer (PFE) downgraded to Hold from Buy at Jefferies with analyst Jeffrey Holford citing a lack of positive catalysts. 3. Coach (COH) downgraded to Mixed from Positive at OTR Global citing checks that indicate less competitive offerings, reduced promotions, and feedback of some share loss by store managers. 4. E-Trade (ETFC) downgraded to Neutral from Buy at BofA/Merrill. 5. Deckers Brands (DECK) downgraded to Negative from Neutral at Susquehanna with analyst Sam Poser saying he believes the health of the UGG brand is clearly at risk as the company has already started promotional activity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

INBK

First Internet Bancorp

$40.15

-0.35 (-0.86%)

16:46
01/18/18
01/18
16:46
01/18/18
16:46
Earnings
First Internet Bancorp reports Q4 adjusted EPS 63c, consensus 62c »

Reports Q4 net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGLC

Pershing Gold

$2.42

-0.01 (-0.41%)

16:45
01/18/18
01/18
16:45
01/18/18
16:45
Syndicate
Breaking Syndicate news story on Pershing Gold »

Pershing Gold files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:43
01/18/18
01/18
16:43
01/18/18
16:43
General news
Fed Balance Sheet Level data reported »

Week of 1/17 Fed Balance…

16:43
01/18/18
01/18
16:43
01/18/18
16:43
General news
Money Supply M2 Weekly Change data reported »

Week of 1/8 Money Supply…

BJRI

BJ's Restaurants

$37.90

-0.1 (-0.26%)

16:42
01/18/18
01/18
16:42
01/18/18
16:42
Hot Stocks
Integrated Core Strategies reports 5.2% passive stake in BJ's Restaurants »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNO

Vornado

$71.34

0.04 (0.06%)

16:41
01/18/18
01/18
16:41
01/18/18
16:41
Earnings
Vornado reports special items impacting Q4 financial results »

Vornado's Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTCT

NetScout

$26.78

0.175 (0.66%)

16:38
01/18/18
01/18
16:38
01/18/18
16:38
Hot Stocks
NetScout enters into amended credit agreement »

On January 16, NetScout…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

NBLX

Noble Midstream

$55.58

-0.02 (-0.04%)

16:35
01/18/18
01/18
16:35
01/18/18
16:35
Hot Stocks
Salient reports 6.23% passive stake in Noble Midstream »

This stake does not allow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 20

    Feb

HHS

Harte-Hanks

16:35
01/18/18
01/18
16:35
01/18/18
16:35
Hot Stocks
Harte-Hanks COO/CTO Shirish Lal leaving the company »

Harte Hanks announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWGH

GWG Holdings

$8.10

-0.2 (-2.41%)

16:35
01/18/18
01/18
16:35
01/18/18
16:35
Hot Stocks
Breaking Hot Stocks news story on GWG Holdings »

GWG Holdings trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPB

Spectrum Brands

$121.30

-3.86 (-3.08%)

16:32
01/18/18
01/18
16:32
01/18/18
16:32
Hot Stocks
Spectrum Brands postpones 2018 annual shareholder meeting »

Spectrum Brands Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 30

    Jan

  • 08

    Feb

NTIP

Network-1 Technologies

$2.50

0.05 (2.04%)

, JNPR

Juniper

$27.66

-1.01 (-3.52%)

16:32
01/18/18
01/18
16:32
01/18/18
16:32
Hot Stocks
Network-1 Technologies announces revised patent settlement with Juniper »

Network-1 Technologies…

NTIP

Network-1 Technologies

$2.50

0.05 (2.04%)

JNPR

Juniper

$27.66

-1.01 (-3.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

ENFC

Entegra Financial

$28.90

-0.7 (-2.36%)

16:31
01/18/18
01/18
16:31
01/18/18
16:31
Earnings
Entegra Financial reports Q4 core EPS 54c, consensus 38c »

Reports Q4 net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

16:30
01/18/18
01/18
16:30
01/18/18
16:30
Options
Preliminary option volume of 20.9M today »

Preliminary option volume…

NTES

NetEase

$322.19

-2.21 (-0.68%)

16:29
01/18/18
01/18
16:29
01/18/18
16:29
Recommendations
NetEase analyst commentary  »

NetEase price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

MS

Morgan Stanley

$55.84

0.49 (0.89%)

, AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

16:25
01/18/18
01/18
16:25
01/18/18
16:25
General news
On The Fly: Top stock stories for Thursday »

Stocks opened little…

MS

Morgan Stanley

$55.84

0.49 (0.89%)

AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

LGF.A

Lionsgate

$34.50

2.22 (6.88%)

LGF.B

Lionsgate

$32.84

2.46 (8.10%)

CBS

CBS

$60.00

1.1 (1.87%)

VIA

Viacom

$39.70

1.85 (4.89%)

VIAB

Viacom

$33.95

1.99 (6.23%)

BA

Boeing

$340.16

-10.85 (-3.09%)

ERJ

Embraer

$24.50

-0.19 (-0.77%)

GNC

GNC Holdings

$5.26

1.79 (51.59%)

PTC

PTC

$69.95

3.25 (4.87%)

AA

Alcoa

$53.00

-3.99 (-7.00%)

ENDP

Endo

$7.35

-0.34 (-4.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 19

    Jan

  • 31

    Jan

  • 01

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 15

    Feb

  • 21

    Feb

  • 18

    Mar

SRG

Seritage Growth Properties

$40.37

-0.4 (-0.98%)

16:25
01/18/18
01/18
16:25
01/18/18
16:25
Hot Stocks
Seritage Growth Properties sees FY17 leasing activity 2.6M sqf, up 26% on year »

Seritage Growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNST

Monster Beverage

$66.47

-0.6 (-0.89%)

16:25
01/18/18
01/18
16:25
01/18/18
16:25
Conference/Events
Monster Beverage to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

MGM

MGM Resorts

$36.07

-0.47 (-1.29%)

, WYNN

Wynn Resorts

$175.48

1.89 (1.09%)

16:23
01/18/18
01/18
16:23
01/18/18
16:23
Initiation
MGM Resorts, Wynn Resorts, Eldorado Resorts, Penn National initiated  »

MGM Resorts initiated…

MGM

MGM Resorts

$36.07

-0.47 (-1.29%)

WYNN

Wynn Resorts

$175.48

1.89 (1.09%)

ERI

Eldorado Resorts

$31.60

-0.4 (-1.25%)

PENN

Penn National

$32.26

-0.49 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BANF

BancFirst

$55.20

0.95 (1.75%)

16:22
01/18/18
01/18
16:22
01/18/18
16:22
Hot Stocks
BancFirst to raise company minimum wage »

Executive Chairman David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$23.82

-0.3 (-1.24%)

16:22
01/18/18
01/18
16:22
01/18/18
16:22
Hot Stocks
Meritor realigns segments and leadership positions »

Meritor is realigning its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 13

    Feb

  • 14

    Feb

BANF

BancFirst

$55.20

0.95 (1.75%)

16:21
01/18/18
01/18
16:21
01/18/18
16:21
Earnings
BancFirst reports Q4 EPS 59c, consensus 69c »

Due to the signing of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHN

athenahealth

$125.53

-0.65 (-0.52%)

16:20
01/18/18
01/18
16:20
01/18/18
16:20
Initiation
athenahealth initiated  »

athenahealth initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

VIX

Volatility Index S&P 500 Options

16:20
01/18/18
01/18
16:20
01/18/18
16:20
Options
Closing CBOE SPX and VIX Index summary for January 18th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$99.86

-0.9 (-0.89%)

16:19
01/18/18
01/18
16:19
01/18/18
16:19
Hot Stocks
Breaking Hot Stocks news story on American Express »

American Express down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.